CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals (“Meitheal”), a fully integrated generic injectables company based in Chicago, is proud to be ranked #4 on Crain’s Chicago Business 2023 Fast 50.
CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated generic injectables company based in Chicago, today announced it has entered into a $35 million senior secured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback